Phase 1 N=34 Treatment

Speech Recognition Training in Children With Hearing Loss

Hearing Loss

Bottom Line

View on ClinicalTrials.gov: NCT04041440 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Nov 2021

Primary outcome: Primary: Percentage of Words Identified Before and After Training — 49.7; 55.7 percentage of words presented

Study Design & Population

Study type: Interventional
Phase: Phase 1
Interventions: clEAR auditory training (Behavioral)
Age: Pediatric · 8+ yrs
Sex: All
Sponsor: Washington University School of Medicine
Primary completion: Sep 2020

Outcome Measures

Outcome	Result	p-value
PRIMARY Percentage of Words Identified Before and After Training	49.7; 55.7	—
SECONDARY Processing Speed	—	—
SECONDARY Working Memory	—	—
SECONDARY Subjective Assessment of clEAR Games on a 7-Point Scale	5.25	—

Summary

clEAR's auditory brain training has been shown to be effective in improving childrens' abilities to recognize the speech of generic talkers in a laboratory setting. In the proposed research, the researchers will build upon these results and assess the extent to which auditory brain training delivered via the web enhances children's abilities to recognize the speech of a potential classroom teacher and diminishes their communication challenges that are associated with significant hearing loss. First, investigators will conduct focus groups with children who have undergone training with the research version of clEAR's pediatric games, then they will recode the games from LabView to Java Script, making changes in the games in response to the focus group comments, and finally, they will collect data from 20 children to assess whether web-based auditory brain training improves their abilities to recognize the speech of their (hypothetical) upcoming school year's classroom teacher.

Eligibility Criteria

Inclusion Criteria

Children with moderate to severe hearing loss.

Exclusion Criteria

Must be native English speakers

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04041440). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.